Cargando…

IgG Glyco-Engineering to Improve IVIg Potency

Intravenous immunoglobulins (IVIg) are used in the treatment of different autoimmune and inflammatory diseases, such as immune thrombocytopenia and hemolytic anemia. One of the modes of action of IVIg is preventing phagocytosis of autoantibody-opsonized blood cells by saturation of the Fc-gamma rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruggeman, Christine W., Dekkers, Gillian, Visser, Remco, Goes, Naneth W. M., van den Berg, Timo K., Rispens, Theo, Vidarsson, Gestur, Kuijpers, Taco W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206079/ https://www.ncbi.nlm.nih.gov/pubmed/30405631 http://dx.doi.org/10.3389/fimmu.2018.02442

Ejemplares similares

Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans
por: Dekkers, Gillian, et al.
Publicado: (2016)

IgG Subclasses and Allotypes: From Structure to Effector Functions
por: Vidarsson, Gestur, et al.
Publicado: (2014)

Dimeric IgG complexes from IVIg are incapable of inducing in vitro neutrophil degranulation or complement activation
por: Kustiawan, Iwan, et al.
Publicado: (2018)

The Ligands for Human IgG and Their Effector Functions
por: de Taeye, Steven W., et al.
Publicado: (2019)

Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases
por: Dekkers, Gillian, et al.
Publicado: (2018)

Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3)
por: Plomp, Rosina, et al.
Publicado: (2015)

C-Reactive Protein Enhances IgG-Mediated Cellular Destruction Through IgG-Fc Receptors in vitro
por: Temming, A. Robin, et al.
Publicado: (2021)

Human DC-SIGN and CD23 do not interact with human IgG
por: Temming, A. Robin, et al.
Publicado: (2019)

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
por: Schriek, Angela I., et al.
Publicado: (2022)

Author Correction: Human DC-SIGN and CD23 do not interact with human IgG
por: Temming, A. Robin, et al.
Publicado: (2020)

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
por: Schriek, Angela I., et al.
Publicado: (2022)

MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N-Glycosylation
por: Sénard, Thomas, et al.
Publicado: (2020)

On the Perplexingly Low Rate of Transport of IgG2 across the Human Placenta
por: Einarsdottir, Helga K., et al.
Publicado: (2014)

Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities
por: Dekkers, Gillian, et al.
Publicado: (2017)

Factors affecting IgG4-mediated complement activation
por: Oskam, Nienke, et al.
Publicado: (2023)

Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?
por: Nagelkerke, Sietse Q., et al.
Publicado: (2015)

Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice
por: Braster, Rens, et al.
Publicado: (2017)

Dynamics of Inter-heavy Chain Interactions in Human Immunoglobulin G (IgG) Subclasses Studied by Kinetic Fab Arm Exchange
por: Rispens, Theo, et al.
Publicado: (2014)

Tissue-specific expression of IgG receptors by human macrophages ex vivo
por: Bruggeman, Christine W., et al.
Publicado: (2019)

FcγR Binding and ADCC Activity of Human IgG Allotypes
por: de Taeye, Steven W., et al.
Publicado: (2020)

Immunoassay for quantification of antigen-specific IgG fucosylation
por: Šuštić, Tonći, et al.
Publicado: (2022)

Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice
por: Braster, Rens, et al.
Publicado: (2021)

Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo
por: Cattepoel, Susann, et al.
Publicado: (2016)

Biophysical Evaluation of Rhesus Macaque Fc Gamma Receptors Reveals Similar IgG Fc Glycoform Preferences to Human Receptors
por: Crowley, Andrew R., et al.
Publicado: (2021)

The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement
por: Brinkhaus, Maximilian, et al.
Publicado: (2022)

Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn
por: Kapur, Rick, et al.
Publicado: (2014)

Afucosylated IgG responses in humans – structural clues to the regulation of humoral immunity
por: Oosterhoff, Janita J., et al.
Publicado: (2022)

Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies
por: Sonneveld, Myrthe E., et al.
Publicado: (2018)

The unique properties of IgG4 and its roles in health and disease
por: Rispens, Theo, et al.
Publicado: (2023)

Human IgE does not bind to human FcRn
por: Brinkhaus, Maximilian, et al.
Publicado: (2022)

Treatment of scleromyxedema with IVIg
por: Moser, David W, et al.
Publicado: (2012)

MALDI-TOF-MS reveals differential N-linked plasma- and IgG-glycosylation profiles between mothers and their newborns
por: Jansen, Bas C., et al.
Publicado: (2016)

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
por: Larsen, Mads Delbo, et al.
Publicado: (2021)

Optimized Protocols for In-Vitro T-Cell-Dependent and T-Cell-Independent Activation for B-Cell Differentiation Studies Using Limited Cells
por: Marsman, Casper, et al.
Publicado: (2022)

Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor
por: Capraz, Tümay, et al.
Publicado: (2021)

Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation
por: Crooks, Ema T., et al.
Publicado: (2018)

Affinity capillary electrophoresis – mass spectrometry permits direct binding assessment of IgG and FcγRIIa in a glycoform-resolved manner
por: Gstöttner, Christoph, et al.
Publicado: (2022)

IgG4-Related Fibrotic Diseases from an Immunological Perspective: Regulators out of Control?
por: Lighaam, Laura C., et al.
Publicado: (2012)

GlycoBioinformatics
por: Aoki-Kinoshita, Kiyoko F, et al.
Publicado: (2021)

Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines
por: Van Coillie, Julie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_boq9uo5ir380juejajdh4kc4ji